103 related articles for article (PubMed ID: 1318977)
1. Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.
Lee JS; Libshitz HI; Fossella FV; Murphy WK; Pang AC; Lippman SM; Shin DM; Dimery IW; Glisson BS; Hong WK
J Natl Cancer Inst; 1992 Jul; 84(13):1039-40. PubMed ID: 1318977
[No Abstract] [Full Text] [Related]
2. Alleviation by leucovorin of the dose-limiting toxicity of edatrexate: potential for improved therapeutic efficacy.
Lee JS; Murphy WK; Shirinian MH; Pang A; Hong WK
Cancer Chemother Pharmacol; 1991; 28(3):199-204. PubMed ID: 1649705
[TBL] [Abstract][Full Text] [Related]
3. Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.
Lee JS; Libshitz HI; Fossella FV; Murphy WK; Pang AC; Lippman SM; Shin DM; Dimery IW; Glisson BS; Hong WK
Cancer; 1991 Sep; 68(5):959-64. PubMed ID: 1655220
[TBL] [Abstract][Full Text] [Related]
4. Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Laurie SA; Pfister DG; Kris MG; Tong WP; Chronowski G; Pisters KM; Heelan RT; Sirotnak FM
Clin Cancer Res; 2001 Mar; 7(3):501-9. PubMed ID: 11297240
[TBL] [Abstract][Full Text] [Related]
5. Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis.
Perez EA; Hack FM; Webber LM; Chou TC
Cancer Chemother Pharmacol; 1993; 33(3):245-50. PubMed ID: 8269606
[TBL] [Abstract][Full Text] [Related]
6. Edatrexate studies in non-small cell lung cancer.
Gralla RJ
Lung Cancer; 1995 Apr; 12 Suppl 1():S187-91. PubMed ID: 7551928
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study.
Gandara DR; Edelman MJ; Crowley JJ; Lau DH; Livingston RB
Cancer Chemother Pharmacol; 1997; 41(1):75-8. PubMed ID: 9443617
[TBL] [Abstract][Full Text] [Related]
8. An important new drug and regimen for non-small-cell lung Ca.
Oncology (Williston Park); 1990 Oct; 4(10):21. PubMed ID: 1963314
[No Abstract] [Full Text] [Related]
9. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
[TBL] [Abstract][Full Text] [Related]
11. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
[TBL] [Abstract][Full Text] [Related]
12. [MEP therapy of advanced lung cancer].
Komuro Y; Ohnishi M; Saitoh A; Morohashi Y
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2688-91. PubMed ID: 2820313
[TBL] [Abstract][Full Text] [Related]
13. [5-FU-leucovorin and cisplatin sequential chemotherapy with dipyridamole for non-small cell lung cancer (NSCLC). A pilot study for 5 cases].
Nakano S; Mitsugi K; Ichinose I; Kuroki M; Anzai K; Nakamura M; Niho Y
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1375-8. PubMed ID: 1648892
[No Abstract] [Full Text] [Related]
14. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
Holmes FA
Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
[TBL] [Abstract][Full Text] [Related]
15. [Postoperative adjuvant treatment for non-small cell lung cancer].
Ichinose Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2470-4. PubMed ID: 12506468
[TBL] [Abstract][Full Text] [Related]
16. [Clinical advances in the chemotherapy of non-small cell lung cancer].
Liao ML; Cheng BJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):480-2. PubMed ID: 15312563
[No Abstract] [Full Text] [Related]
17. [Treatment of non-small cell bronchopulmonary carcinoma with the combination of cyclophosphamide, adriamycin and cisplatin].
Donnay Candil O; Jiménez Berlana U
Rev Esp Oncol; 1983; 30(4):603-10. PubMed ID: 6100970
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of small cell lung cancer].
Ueoka H; Ohnoshi T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2571-7. PubMed ID: 7979415
[TBL] [Abstract][Full Text] [Related]
19. Is chemotherapy for metastatic non-small cell lung cancer "worth it"?
Ruckdeschel JC
J Clin Oncol; 1990 Aug; 8(8):1293-6. PubMed ID: 2166141
[No Abstract] [Full Text] [Related]
20. Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E; Zipoli T; Gonzalves L
J Infus Chemother; 1996; 6(1):43-6. PubMed ID: 8748007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
